Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECORD-1: RAD001 (Everolimus) in Metastatic Renal Cell Carcinoma
NCT00410124Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of everolimus in metastatic renal cell carcinoma (mRCC), sponsored by Novartis. Started Nov 2006; status: completed.
02
Drugs
everolimus
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on NCT00410124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00410124.